Unlock the Editor’s Digest without spending a dime
Roula Khalaf, Editor of the FT, selects her favorite tales on this weekly publication.
US pharmacy chain Walgreens Boots Alliance is in talks over a sale to a non-public fairness agency, underscoring the rising strains dealing with the sector.
The Illinois-based group is in discussions with Sycamore Companions, an funding group recognized for focusing on troubled retailers, mentioned two folks acquainted with the matter.
Excessive inflation, which has pushed down customers’ disposable revenue, and rising competitors have put stress on the group’s greater than 12,500 places throughout the US, Europe and Latin America. The group in October mentioned it might shut 1,200 shops in coming years because it reported a virtually $9bn web loss for its 2024 fiscal yr.
Walgreens, which owns the UK’s Boots chain, had a market worth of as a lot as $106bn in 2015, however a share rout pushed that determine all the way down to about $8bn as of Monday’s shut. Its inventory rose nearly 20 per cent on Tuesday after The Wall Road Journal first reported on the negotiations.
The talks with Sycamore spotlight how the out there choices for Walgreens have dwindled since 2019, when the chain was provided $70bn to promote to personal fairness agency KKR in what would have been the biggest personal fairness transaction.
The greater than century previous retailer had for many years risen on the general public markets, culminating in a worldwide enlargement when Walgreens purchased Boots for about $20bn in a two-step transaction began in 2012 and accomplished two years later. However rivals akin to Amazon and Goal have progressively chipped away at its enterprise, prompting Walgreens to repeatedly attempt to promote or publicly record Boots to concentrate on its US operations.
Walgreens final yr appointed Tim Wentworth, a former Cigna govt, as chief govt. He took over from earlier CEO Rosalind Brewer, who stepped down after a two-year interval wherein the group’s shares halved and acquisitions of healthcare group Summit Well being-CityMD and home-care supplier CareCentrix didn’t repay.
US retail pharmacies akin to Walgreens and Ceremony Help have struggled within the public markets, with the latter submitting for Chapter 11 chapter safety in 2023, permitting it to restructure billions of {dollars} in debt. CVS Well being lately added 4 new board members in a pact with activist investor Glenview Administration, though the retailer’s diversification into medical health insurance and pharmacy profit administration has helped bolster its enterprise.
A deal for Walgreens can be a giant wager for Sycamore, which manages $10bn, prompting predictions from analysts that the New York-based buyout agency is prone to want outdoors companions to take the retailer off of the general public market.
Sycamore and Walgreens declined to remark.
It was unclear whether or not Walgreens would stay in a single piece or be hived off into a number of elements below Sycamore possession. Regardless, “a restructuring of [Walgreens] would possible be simpler outdoors of public eyes”, Elizabeth Anderson, an analyst at Evercore mentioned.
Sycamore has invested in distressed brick-and-mortar centered retailers together with Loft and Scorching Matter. In 2017, it purchased workplace provide retailer Staples for $7bn. One of many agency’s senior advisers, John Lederer holds a seat on Walgreens’s board, a job held since 2015.
